O	0	6	Effect
O	7	9	of
B-intervention	10	23	penehyclidine
I-intervention	24	37	hydrochloride
O	38	40	on
O	41	44	the
B-condition	45	54	incidence
I-condition	55	57	of
I-condition	58	63	intra
I-condition	63	64	-
I-condition	64	73	operative
I-condition	74	83	awareness
O	84	86	in
B-ethinicity	87	94	Chinese
O	95	103	patients
O	104	114	undergoing
O	115	121	breast
O	122	128	cancer
O	129	136	surgery
O	137	143	during
O	144	151	general
O	152	163	anaesthesia
O	163	164	.

O	165	170	Intra
O	170	171	-
O	171	180	operative
O	181	190	awareness
O	191	194	can
O	195	199	lead
O	200	202	to
O	203	210	serious
O	211	218	adverse
O	219	232	psychological
O	233	245	consequences
O	245	246	.

O	247	249	We
O	250	259	conducted
O	260	261	a
O	262	273	prospective
O	273	274	,
O	275	285	randomised
O	285	286	,
O	287	293	double
O	293	294	-
O	294	301	blinded
O	302	307	trial
O	308	310	in
B-total-participants	311	314	920
B-eligibility	315	323	patients
I-eligibility	324	334	undergoing
I-eligibility	335	341	breast
I-eligibility	342	348	cancer
I-eligibility	349	356	surgery
I-eligibility	357	362	under
I-eligibility	363	373	bispectral
I-eligibility	374	379	index
I-eligibility	379	380	-
I-eligibility	380	386	guided
I-eligibility	387	392	total
I-eligibility	393	404	intravenous
I-eligibility	405	416	anaesthesia
O	417	419	to
O	420	428	evaluate
O	429	432	the
O	433	439	effect
O	440	442	of
O	443	456	penehyclidine
O	457	470	hydrochloride
O	471	473	on
O	474	479	intra
O	479	480	-
O	480	489	operative
O	490	499	awareness
O	499	500	.

O	501	509	Patients
O	510	514	were
O	515	523	randomly
O	524	531	divided
O	532	534	to
O	535	542	receive
O	543	544	0
O	544	545	.
O	545	547	01
O	548	550	mg
O	550	551	.
O	551	553	kg
O	553	554	(
O	554	555	-
O	555	556	1
O	556	557	)
O	559	572	penehyclidine
O	573	586	hydrochloride
O	587	589	or
B-control	590	596	saline
O	597	610	intravenously
O	611	613	30
O	614	617	min
O	618	624	before
O	625	632	surgery
O	632	633	.

O	634	637	The
O	638	641	pre
O	641	642	-
O	642	656	administration
O	656	657	,
O	658	661	pre
O	661	662	-
O	662	671	operative
O	672	679	anxiety
O	680	686	levels
O	687	691	were
O	692	700	assessed
O	701	706	using
O	707	708	a
O	709	712	100
O	712	713	-
O	713	715	mm
O	716	722	visual
O	723	731	analogue
O	732	737	scale
O	737	738	.

O	739	744	Intra
O	744	745	-
O	745	754	operative
O	755	764	awareness
O	765	768	was
O	769	776	defined
O	777	779	as
O	780	786	recall
O	787	789	of
O	790	795	intra
O	795	796	-
O	796	805	operative
O	806	812	events
O	813	818	using
O	819	820	a
O	821	829	modified
O	830	835	Brice
O	836	845	interview
O	846	858	administered
O	859	860	2
O	860	861	-
O	861	862	6
O	863	864	h
O	865	880	postoperatively
O	880	881	,
O	882	885	and
O	886	888	in
O	889	892	the
O	893	897	next
O	898	900	24
O	900	901	-
O	901	903	48
O	904	905	h
O	905	906	.

O	907	908	A
O	909	918	committee
O	919	921	of
O	922	927	three
O	928	935	experts
O	935	936	,
O	937	944	blinded
O	945	947	to
O	948	951	the
O	952	957	study
O	958	968	conditions
O	968	969	,
O	970	983	independently
O	984	995	scrutinised
O	996	999	all
O	1000	1008	reported
O	1009	1022	recollections
O	1022	1023	.

O	1024	1026	We
O	1027	1032	found
O	1033	1035	no
O	1036	1047	differences
O	1048	1050	in
O	1051	1056	depth
O	1057	1059	of
O	1060	1071	anaesthesia
O	1072	1075	and
O	1076	1084	patients
O	1084	1085	'
O	1086	1089	pre
O	1089	1090	-
O	1090	1099	operative
B-outcome	1100	1107	anxiety
I-outcome	1108	1114	levels
O	1115	1122	between
O	1123	1126	the
O	1127	1130	two
O	1131	1137	groups
O	1137	1138	.

O	1139	1142	The
B-outcome	1143	1152	incidence
I-outcome	1153	1155	of
I-outcome	1156	1165	awareness
O	1166	1170	with
O	1171	1184	penehyclidine
O	1185	1198	hydrochloride
O	1199	1200	(
B-iv-bin-abs	1200	1201	0
O	1201	1202	/
B-intervention-participants	1202	1205	456
O	1206	1214	patients
O	1214	1215	;
B-iv-bin-percent	1216	1217	0
I-iv-bin-percent	1217	1218	%
O	1218	1219	)
O	1220	1223	was
O	1224	1237	significantly
O	1238	1243	lower
O	1244	1248	than
O	1249	1253	with
O	1254	1260	saline
O	1261	1262	(
B-cv-bin-abs	1262	1263	5
O	1263	1264	/
B-control-participants	1264	1267	452
O	1267	1268	;
B-cv-bin-percent	1269	1270	1
I-cv-bin-percent	1270	1271	.
I-cv-bin-percent	1271	1272	1
I-cv-bin-percent	1272	1273	%
O	1273	1274	)
O	1274	1275	,
O	1276	1277	p
O	1278	1279	=
O	1280	1281	0
O	1281	1282	.
O	1282	1285	030
O	1285	1286	.

O	1287	1289	We
O	1290	1298	conclude
O	1299	1303	that
O	1304	1317	penehyclidine
O	1318	1331	hydrochloride
O	1332	1339	reduced
O	1340	1343	the
O	1344	1353	incidence
O	1354	1356	of
O	1357	1362	intra
O	1362	1363	-
O	1363	1372	operative
O	1373	1382	awareness
O	1383	1385	in
O	1386	1394	patients
O	1395	1405	undergoing
O	1406	1412	breast
O	1413	1419	cancer
O	1420	1427	surgery
O	1428	1434	during
O	1435	1442	general
O	1443	1454	anaesthesia
O	1454	1455	.
